A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Clinical trial NCT05721573 · COMPLETED

Trial details

NCT number: NCT05721573
Sponsor: Abcuro, Inc.
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Inclusion Body Myositis

Start date: 2023-02-28
Primary completion: 2025-11-06
Enrollment: 272

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.